Cellectis S.A. Files Form 6-K
Ticker: CLLS · Form: 6-K · Filed: Oct 16, 2025 · CIK: 1627281
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, sec-compliance
TL;DR
Cellectis S.A. filed a 6-K on Oct 16, 2025, confirming its foreign private issuer status and 20-F filing for US investors.
AI Summary
Cellectis S.A. filed a Form 6-K on October 16, 2025, reporting as a foreign private issuer. The company, based in Paris, France, is involved in the biological products sector and is subject to US securities regulations, filing annual reports under Form 20-F.
Why It Matters
This filing indicates ongoing compliance and reporting by Cellectis S.A. with the U.S. Securities and Exchange Commission, which is important for investors tracking the company's regulatory activities.
Risk Assessment
Risk Level: low — This is a routine regulatory filing and does not contain new financial or operational information that would immediately impact risk.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- October 16, 2025 (date) — Filing Date
- Paris, France (location) — Company Headquarters
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Filing
FAQ
What is the primary purpose of this Form 6-K filing by Cellectis S.A.?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, indicating ongoing reporting obligations.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on October 16, 2025.
Does Cellectis S.A. file its annual reports under Form 20-F or Form 40-F?
Cellectis S.A. indicates it files its annual reports under cover of Form 20-F.
Where is Cellectis S.A. headquartered?
Cellectis S.A. is headquartered at 8, rue de la Croix Jarry, 75013 Paris, France.
What is the Commission File Number for Cellectis S.A.?
The Commission File Number for Cellectis S.A. is 001-36891.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 9.9 · Accepted 2025-10-16 07:05:06
Filing Documents
- f6k_101625.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 7KB
- 0001171843-25-006470.txt ( ) — 14KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: October 16, 2025 /s/ Andr Choulika Andr Choulika Chief Executive Officer